participant
-
Neuro
Medtronic participates in $6.8m Mayo Clinic epilepsy project
By Fink Densford Medtronic (NYSE:MDT) will be joining the Mayo Clinic in a new $6.8 million National Institutes of Health funded project to develop…
Read More » -
Biologics
RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis
ReaCT Trial at University of British Columbia Treating Patients with Autologous Cell Therapy VANCOUVER, June 30, 2015 /PRNewswire/ – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V:…
Read More »